Global Oncology Targeted Therapy Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Description

According to our (Global Info Research) latest study, the global Oncology Targeted Therapy market size was valued at US$ 63450 million in 2024 and is forecast to a readjusted size of USD 115840 million by 2031 with a CAGR of 9.1% during review period.

Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report is a detailed and comprehensive analysis for global Oncology Targeted Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Oncology Targeted Therapy market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oncology Targeted Therapy market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oncology Targeted Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Oncology Targeted Therapy market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology Targeted Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology Targeted Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche, Bristol-Myers Squibb, Pfizer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Oncology Targeted Therapy market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Sorafenib
    Lenvatinib
    Regorafenib
    Osimertinib
    Anlotinib
    Alectinib
    Other

Market segment by Application
    Hospital
    Retail Pharmacy
    Other

Market segment by players, this report covers
    Bayer
    Eisai
    Zelgen
    Cipla
    Natco Pharma
    AstraZeneca
    Novartis
    Roche
    Bristol-Myers Squibb
    Pfizer
    BEACON Pharma
    Jiangxi Shanxiang
    Yao Pharma
    CSPC
    CHIATAI Tianqing
    Simcere

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology Targeted Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Targeted Therapy, with revenue, gross margin, and global market share of Oncology Targeted Therapy from 2020 to 2025.
Chapter 3, the Oncology Targeted Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oncology Targeted Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Targeted Therapy.
Chapter 13, to describe Oncology Targeted Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Oncology Targeted Therapy by Type
        1.3.1 Overview: Global Oncology Targeted Therapy Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global Oncology Targeted Therapy Consumption Value Market Share by Type in 2024
        1.3.3 Sorafenib
        1.3.4 Lenvatinib
        1.3.5 Regorafenib
        1.3.6 Osimertinib
        1.3.7 Anlotinib
        1.3.8 Alectinib
        1.3.9 Other
    1.4 Global Oncology Targeted Therapy Market by Application
        1.4.1 Overview: Global Oncology Targeted Therapy Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Hospital
        1.4.3 Retail Pharmacy
        1.4.4 Other
    1.5 Global Oncology Targeted Therapy Market Size & Forecast
    1.6 Global Oncology Targeted Therapy Market Size and Forecast by Region
        1.6.1 Global Oncology Targeted Therapy Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global Oncology Targeted Therapy Market Size by Region, (2020-2031)
        1.6.3 North America Oncology Targeted Therapy Market Size and Prospect (2020-2031)
        1.6.4 Europe Oncology Targeted Therapy Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific Oncology Targeted Therapy Market Size and Prospect (2020-2031)
        1.6.6 South America Oncology Targeted Therapy Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa Oncology Targeted Therapy Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 Bayer
        2.1.1 Bayer Details
        2.1.2 Bayer Major Business
        2.1.3 Bayer Oncology Targeted Therapy Product and Solutions
        2.1.4 Bayer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 Bayer Recent Developments and Future Plans
    2.2 Eisai
        2.2.1 Eisai Details
        2.2.2 Eisai Major Business
        2.2.3 Eisai Oncology Targeted Therapy Product and Solutions
        2.2.4 Eisai Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Eisai Recent Developments and Future Plans
    2.3 Zelgen
        2.3.1 Zelgen Details
        2.3.2 Zelgen Major Business
        2.3.3 Zelgen Oncology Targeted Therapy Product and Solutions
        2.3.4 Zelgen Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Zelgen Recent Developments and Future Plans
    2.4 Cipla
        2.4.1 Cipla Details
        2.4.2 Cipla Major Business
        2.4.3 Cipla Oncology Targeted Therapy Product and Solutions
        2.4.4 Cipla Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 Cipla Recent Developments and Future Plans
    2.5 Natco Pharma
        2.5.1 Natco Pharma Details
        2.5.2 Natco Pharma Major Business
        2.5.3 Natco Pharma Oncology Targeted Therapy Product and Solutions
        2.5.4 Natco Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Natco Pharma Recent Developments and Future Plans
    2.6 AstraZeneca
        2.6.1 AstraZeneca Details
        2.6.2 AstraZeneca Major Business
        2.6.3 AstraZeneca Oncology Targeted Therapy Product and Solutions
        2.6.4 AstraZeneca Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 AstraZeneca Recent Developments and Future Plans
    2.7 Novartis
        2.7.1 Novartis Details
        2.7.2 Novartis Major Business
        2.7.3 Novartis Oncology Targeted Therapy Product and Solutions
        2.7.4 Novartis Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.7.5 Novartis Recent Developments and Future Plans
    2.8 Roche
        2.8.1 Roche Details
        2.8.2 Roche Major Business
        2.8.3 Roche Oncology Targeted Therapy Product and Solutions
        2.8.4 Roche Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.8.5 Roche Recent Developments and Future Plans
    2.9 Bristol-Myers Squibb
        2.9.1 Bristol-Myers Squibb Details
        2.9.2 Bristol-Myers Squibb Major Business
        2.9.3 Bristol-Myers Squibb Oncology Targeted Therapy Product and Solutions
        2.9.4 Bristol-Myers Squibb Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.9.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.10 Pfizer
        2.10.1 Pfizer Details
        2.10.2 Pfizer Major Business
        2.10.3 Pfizer Oncology Targeted Therapy Product and Solutions
        2.10.4 Pfizer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.10.5 Pfizer Recent Developments and Future Plans
    2.11 BEACON Pharma
        2.11.1 BEACON Pharma Details
        2.11.2 BEACON Pharma Major Business
        2.11.3 BEACON Pharma Oncology Targeted Therapy Product and Solutions
        2.11.4 BEACON Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.11.5 BEACON Pharma Recent Developments and Future Plans
    2.12 Jiangxi Shanxiang
        2.12.1 Jiangxi Shanxiang Details
        2.12.2 Jiangxi Shanxiang Major Business
        2.12.3 Jiangxi Shanxiang Oncology Targeted Therapy Product and Solutions
        2.12.4 Jiangxi Shanxiang Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.12.5 Jiangxi Shanxiang Recent Developments and Future Plans
    2.13 Yao Pharma
        2.13.1 Yao Pharma Details
        2.13.2 Yao Pharma Major Business
        2.13.3 Yao Pharma Oncology Targeted Therapy Product and Solutions
        2.13.4 Yao Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.13.5 Yao Pharma Recent Developments and Future Plans
    2.14 CSPC
        2.14.1 CSPC Details
        2.14.2 CSPC Major Business
        2.14.3 CSPC Oncology Targeted Therapy Product and Solutions
        2.14.4 CSPC Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.14.5 CSPC Recent Developments and Future Plans
    2.15 CHIATAI Tianqing
        2.15.1 CHIATAI Tianqing Details
        2.15.2 CHIATAI Tianqing Major Business
        2.15.3 CHIATAI Tianqing Oncology Targeted Therapy Product and Solutions
        2.15.4 CHIATAI Tianqing Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.15.5 CHIATAI Tianqing Recent Developments and Future Plans
    2.16 Simcere
        2.16.1 Simcere Details
        2.16.2 Simcere Major Business
        2.16.3 Simcere Oncology Targeted Therapy Product and Solutions
        2.16.4 Simcere Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
        2.16.5 Simcere Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Oncology Targeted Therapy Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of Oncology Targeted Therapy by Company Revenue
        3.2.2 Top 3 Oncology Targeted Therapy Players Market Share in 2024
        3.2.3 Top 6 Oncology Targeted Therapy Players Market Share in 2024
    3.3 Oncology Targeted Therapy Market: Overall Company Footprint Analysis
        3.3.1 Oncology Targeted Therapy Market: Region Footprint
        3.3.2 Oncology Targeted Therapy Market: Company Product Type Footprint
        3.3.3 Oncology Targeted Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Oncology Targeted Therapy Consumption Value and Market Share by Type (2020-2025)
    4.2 Global Oncology Targeted Therapy Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global Oncology Targeted Therapy Consumption Value Market Share by Application (2020-2025)
    5.2 Global Oncology Targeted Therapy Market Forecast by Application (2026-2031)

6 North America
    6.1 North America Oncology Targeted Therapy Consumption Value by Type (2020-2031)
    6.2 North America Oncology Targeted Therapy Market Size by Application (2020-2031)
    6.3 North America Oncology Targeted Therapy Market Size by Country
        6.3.1 North America Oncology Targeted Therapy Consumption Value by Country (2020-2031)
        6.3.2 United States Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        6.3.3 Canada Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        6.3.4 Mexico Oncology Targeted Therapy Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe Oncology Targeted Therapy Consumption Value by Type (2020-2031)
    7.2 Europe Oncology Targeted Therapy Consumption Value by Application (2020-2031)
    7.3 Europe Oncology Targeted Therapy Market Size by Country
        7.3.1 Europe Oncology Targeted Therapy Consumption Value by Country (2020-2031)
        7.3.2 Germany Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        7.3.3 France Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        7.3.5 Russia Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        7.3.6 Italy Oncology Targeted Therapy Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific Oncology Targeted Therapy Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific Oncology Targeted Therapy Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific Oncology Targeted Therapy Market Size by Region
        8.3.1 Asia-Pacific Oncology Targeted Therapy Consumption Value by Region (2020-2031)
        8.3.2 China Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        8.3.3 Japan Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        8.3.4 South Korea Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        8.3.5 India Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        8.3.7 Australia Oncology Targeted Therapy Market Size and Forecast (2020-2031)

9 South America
    9.1 South America Oncology Targeted Therapy Consumption Value by Type (2020-2031)
    9.2 South America Oncology Targeted Therapy Consumption Value by Application (2020-2031)
    9.3 South America Oncology Targeted Therapy Market Size by Country
        9.3.1 South America Oncology Targeted Therapy Consumption Value by Country (2020-2031)
        9.3.2 Brazil Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        9.3.3 Argentina Oncology Targeted Therapy Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa Oncology Targeted Therapy Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa Oncology Targeted Therapy Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa Oncology Targeted Therapy Market Size by Country
        10.3.1 Middle East & Africa Oncology Targeted Therapy Consumption Value by Country (2020-2031)
        10.3.2 Turkey Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia Oncology Targeted Therapy Market Size and Forecast (2020-2031)
        10.3.4 UAE Oncology Targeted Therapy Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 Oncology Targeted Therapy Market Drivers
    11.2 Oncology Targeted Therapy Market Restraints
    11.3 Oncology Targeted Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Oncology Targeted Therapy Industry Chain
    12.2 Oncology Targeted Therapy Upstream Analysis
    12.3 Oncology Targeted Therapy Midstream Analysis
    12.4 Oncology Targeted Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Oncology Targeted Therapy Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Oncology Targeted Therapy Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global Oncology Targeted Therapy Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global Oncology Targeted Therapy Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. Bayer Company Information, Head Office, and Major Competitors
 Table 6. Bayer Major Business
 Table 7. Bayer Oncology Targeted Therapy Product and Solutions
 Table 8. Bayer Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. Bayer Recent Developments and Future Plans
 Table 10. Eisai Company Information, Head Office, and Major Competitors
 Table 11. Eisai Major Business
 Table 12. Eisai Oncology Targeted Therapy Product and Solutions
 Table 13. Eisai Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. Eisai Recent Developments and Future Plans
 Table 15. Zelgen Company Information, Head Office, and Major Competitors
 Table 16. Zelgen Major Business
 Table 17. Zelgen Oncology Targeted Therapy Product and Solutions
 Table 18. Zelgen Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. Cipla Company Information, Head Office, and Major Competitors
 Table 20. Cipla Major Business
 Table 21. Cipla Oncology Targeted Therapy Product and Solutions
 Table 22. Cipla Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 23. Cipla Recent Developments and Future Plans
 Table 24. Natco Pharma Company Information, Head Office, and Major Competitors
 Table 25. Natco Pharma Major Business
 Table 26. Natco Pharma Oncology Targeted Therapy Product and Solutions
 Table 27. Natco Pharma Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 28. Natco Pharma Recent Developments and Future Plans
 Table 29. AstraZeneca Company Information, Head Office, and Major Competitors
 Table 30. AstraZeneca Major Business
 Table 31. AstraZeneca Oncology Targeted Therapy Product and Solutions
 Table 32. AstraZeneca Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 33. AstraZeneca Recent Developments and Future Plans
 Table 34. Novartis Company Information, Head Office, and Major Competitors
 Table 35. Novartis Major Business
 Table 36. Novartis Oncology Targeted Therapy Product and Solutions
 Table 37. Novartis Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 38. Novartis Recent Developments and Future Plans
 Table 39. Roche Company Information, Head Office, and Major Competitors
 Table 40. Roche Major Business
 Table 41. Roche Oncology Targeted Therapy Product and Solutions
 Table 42. Roche Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 43. Roche Recent Developments and Future Plans
 Table 44. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
 Table 45. Bristol-Myers Squibb Major Business
 Table 46. Bristol-Myers Squibb Oncology Targeted Therapy Product and Solutions
 Table 47. Bristol-Myers Squibb Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 48. Bristol-Myers Squibb Recent Developments and Future Plans
 Table 49. Pfizer Company Information, Head Office, and Major Competitors
 Table 50. Pfizer Major Business
 Table 51. Pfizer Oncology Targeted Therapy Product and Solutions
 Table 52. Pfizer Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 53. Pfizer Recent Developments and Future Plans
 Table 54. BEACON Pharma Company Information, Head Office, and Major Competitors
 Table 55. BEACON Pharma Major Business
 Table 56. BEACON Pharma Oncology Targeted Therapy Product and Solutions
 Table 57. BEACON Pharma Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 58. BEACON Pharma Recent Developments and Future Plans
 Table 59. Jiangxi Shanxiang Company Information, Head Office, and Major Competitors
 Table 60. Jiangxi Shanxiang Major Business
 Table 61. Jiangxi Shanxiang Oncology Targeted Therapy Product and Solutions
 Table 62. Jiangxi Shanxiang Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 63. Jiangxi Shanxiang Recent Developments and Future Plans
 Table 64. Yao Pharma Company Information, Head Office, and Major Competitors
 Table 65. Yao Pharma Major Business
 Table 66. Yao Pharma Oncology Targeted Therapy Product and Solutions
 Table 67. Yao Pharma Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 68. Yao Pharma Recent Developments and Future Plans
 Table 69. CSPC Company Information, Head Office, and Major Competitors
 Table 70. CSPC Major Business
 Table 71. CSPC Oncology Targeted Therapy Product and Solutions
 Table 72. CSPC Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 73. CSPC Recent Developments and Future Plans
 Table 74. CHIATAI Tianqing Company Information, Head Office, and Major Competitors
 Table 75. CHIATAI Tianqing Major Business
 Table 76. CHIATAI Tianqing Oncology Targeted Therapy Product and Solutions
 Table 77. CHIATAI Tianqing Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 78. CHIATAI Tianqing Recent Developments and Future Plans
 Table 79. Simcere Company Information, Head Office, and Major Competitors
 Table 80. Simcere Major Business
 Table 81. Simcere Oncology Targeted Therapy Product and Solutions
 Table 82. Simcere Oncology Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 83. Simcere Recent Developments and Future Plans
 Table 84. Global Oncology Targeted Therapy Revenue (USD Million) by Players (2020-2025)
 Table 85. Global Oncology Targeted Therapy Revenue Share by Players (2020-2025)
 Table 86. Breakdown of Oncology Targeted Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 87. Market Position of Players in Oncology Targeted Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 88. Head Office of Key Oncology Targeted Therapy Players
 Table 89. Oncology Targeted Therapy Market: Company Product Type Footprint
 Table 90. Oncology Targeted Therapy Market: Company Product Application Footprint
 Table 91. Oncology Targeted Therapy New Market Entrants and Barriers to Market Entry
 Table 92. Oncology Targeted Therapy Mergers, Acquisition, Agreements, and Collaborations
 Table 93. Global Oncology Targeted Therapy Consumption Value (USD Million) by Type (2020-2025)
 Table 94. Global Oncology Targeted Therapy Consumption Value Share by Type (2020-2025)
 Table 95. Global Oncology Targeted Therapy Consumption Value Forecast by Type (2026-2031)
 Table 96. Global Oncology Targeted Therapy Consumption Value by Application (2020-2025)
 Table 97. Global Oncology Targeted Therapy Consumption Value Forecast by Application (2026-2031)
 Table 98. North America Oncology Targeted Therapy Consumption Value by Type (2020-2025) & (USD Million)
 Table 99. North America Oncology Targeted Therapy Consumption Value by Type (2026-2031) & (USD Million)
 Table 100. North America Oncology Targeted Therapy Consumption Value by Application (2020-2025) & (USD Million)
 Table 101. North America Oncology Targeted Therapy Consumption Value by Application (2026-2031) & (USD Million)
 Table 102. North America Oncology Targeted Therapy Consumption Value by Country (2020-2025) & (USD Million)
 Table 103. North America Oncology Targeted Therapy Consumption Value by Country (2026-2031) & (USD Million)
 Table 104. Europe Oncology Targeted Therapy Consumption Value by Type (2020-2025) & (USD Million)
 Table 105. Europe Oncology Targeted Therapy Consumption Value by Type (2026-2031) & (USD Million)
 Table 106. Europe Oncology Targeted Therapy Consumption Value by Application (2020-2025) & (USD Million)
 Table 107. Europe Oncology Targeted Therapy Consumption Value by Application (2026-2031) & (USD Million)
 Table 108. Europe Oncology Targeted Therapy Consumption Value by Country (2020-2025) & (USD Million)
 Table 109. Europe Oncology Targeted Therapy Consumption Value by Country (2026-2031) & (USD Million)
 Table 110. Asia-Pacific Oncology Targeted Therapy Consumption Value by Type (2020-2025) & (USD Million)
 Table 111. Asia-Pacific Oncology Targeted Therapy Consumption Value by Type (2026-2031) & (USD Million)
 Table 112. Asia-Pacific Oncology Targeted Therapy Consumption Value by Application (2020-2025) & (USD Million)
 Table 113. Asia-Pacific Oncology Targeted Therapy Consumption Value by Application (2026-2031) & (USD Million)
 Table 114. Asia-Pacific Oncology Targeted Therapy Consumption Value by Region (2020-2025) & (USD Million)
 Table 115. Asia-Pacific Oncology Targeted Therapy Consumption Value by Region (2026-2031) & (USD Million)
 Table 116. South America Oncology Targeted Therapy Consumption Value by Type (2020-2025) & (USD Million)
 Table 117. South America Oncology Targeted Therapy Consumption Value by Type (2026-2031) & (USD Million)
 Table 118. South America Oncology Targeted Therapy Consumption Value by Application (2020-2025) & (USD Million)
 Table 119. South America Oncology Targeted Therapy Consumption Value by Application (2026-2031) & (USD Million)
 Table 120. South America Oncology Targeted Therapy Consumption Value by Country (2020-2025) & (USD Million)
 Table 121. South America Oncology Targeted Therapy Consumption Value by Country (2026-2031) & (USD Million)
 Table 122. Middle East & Africa Oncology Targeted Therapy Consumption Value by Type (2020-2025) & (USD Million)
 Table 123. Middle East & Africa Oncology Targeted Therapy Consumption Value by Type (2026-2031) & (USD Million)
 Table 124. Middle East & Africa Oncology Targeted Therapy Consumption Value by Application (2020-2025) & (USD Million)
 Table 125. Middle East & Africa Oncology Targeted Therapy Consumption Value by Application (2026-2031) & (USD Million)
 Table 126. Middle East & Africa Oncology Targeted Therapy Consumption Value by Country (2020-2025) & (USD Million)
 Table 127. Middle East & Africa Oncology Targeted Therapy Consumption Value by Country (2026-2031) & (USD Million)
 Table 128. Global Key Players of Oncology Targeted Therapy Upstream (Raw Materials)
 Table 129. Global Oncology Targeted Therapy Typical Customers


List of Figures
 Figure 1. Oncology Targeted Therapy Picture
 Figure 2. Global Oncology Targeted Therapy Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Oncology Targeted Therapy Consumption Value Market Share by Type in 2024
 Figure 4. Sorafenib
 Figure 5. Lenvatinib
 Figure 6. Regorafenib
 Figure 7. Osimertinib
 Figure 8. Anlotinib
 Figure 9. Alectinib
 Figure 10. Other
 Figure 11. Global Oncology Targeted Therapy Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 12. Oncology Targeted Therapy Consumption Value Market Share by Application in 2024
 Figure 13. Hospital Picture
 Figure 14. Retail Pharmacy Picture
 Figure 15. Other Picture
 Figure 16. Global Oncology Targeted Therapy Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 17. Global Oncology Targeted Therapy Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 18. Global Market Oncology Targeted Therapy Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 19. Global Oncology Targeted Therapy Consumption Value Market Share by Region (2020-2031)
 Figure 20. Global Oncology Targeted Therapy Consumption Value Market Share by Region in 2024
 Figure 21. North America Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 22. Europe Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 23. Asia-Pacific Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 24. South America Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 25. Middle East & Africa Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 26. Company Three Recent Developments and Future Plans
 Figure 27. Global Oncology Targeted Therapy Revenue Share by Players in 2024
 Figure 28. Oncology Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 29. Market Share of Oncology Targeted Therapy by Player Revenue in 2024
 Figure 30. Top 3 Oncology Targeted Therapy Players Market Share in 2024
 Figure 31. Top 6 Oncology Targeted Therapy Players Market Share in 2024
 Figure 32. Global Oncology Targeted Therapy Consumption Value Share by Type (2020-2025)
 Figure 33. Global Oncology Targeted Therapy Market Share Forecast by Type (2026-2031)
 Figure 34. Global Oncology Targeted Therapy Consumption Value Share by Application (2020-2025)
 Figure 35. Global Oncology Targeted Therapy Market Share Forecast by Application (2026-2031)
 Figure 36. North America Oncology Targeted Therapy Consumption Value Market Share by Type (2020-2031)
 Figure 37. North America Oncology Targeted Therapy Consumption Value Market Share by Application (2020-2031)
 Figure 38. North America Oncology Targeted Therapy Consumption Value Market Share by Country (2020-2031)
 Figure 39. United States Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 40. Canada Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 41. Mexico Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 42. Europe Oncology Targeted Therapy Consumption Value Market Share by Type (2020-2031)
 Figure 43. Europe Oncology Targeted Therapy Consumption Value Market Share by Application (2020-2031)
 Figure 44. Europe Oncology Targeted Therapy Consumption Value Market Share by Country (2020-2031)
 Figure 45. Germany Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 46. France Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 47. United Kingdom Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 48. Russia Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 49. Italy Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 50. Asia-Pacific Oncology Targeted Therapy Consumption Value Market Share by Type (2020-2031)
 Figure 51. Asia-Pacific Oncology Targeted Therapy Consumption Value Market Share by Application (2020-2031)
 Figure 52. Asia-Pacific Oncology Targeted Therapy Consumption Value Market Share by Region (2020-2031)
 Figure 53. China Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 54. Japan Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 55. South Korea Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 56. India Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 57. Southeast Asia Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 58. Australia Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 59. South America Oncology Targeted Therapy Consumption Value Market Share by Type (2020-2031)
 Figure 60. South America Oncology Targeted Therapy Consumption Value Market Share by Application (2020-2031)
 Figure 61. South America Oncology Targeted Therapy Consumption Value Market Share by Country (2020-2031)
 Figure 62. Brazil Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 63. Argentina Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 64. Middle East & Africa Oncology Targeted Therapy Consumption Value Market Share by Type (2020-2031)
 Figure 65. Middle East & Africa Oncology Targeted Therapy Consumption Value Market Share by Application (2020-2031)
 Figure 66. Middle East & Africa Oncology Targeted Therapy Consumption Value Market Share by Country (2020-2031)
 Figure 67. Turkey Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 68. Saudi Arabia Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 69. UAE Oncology Targeted Therapy Consumption Value (2020-2031) & (USD Million)
 Figure 70. Oncology Targeted Therapy Market Drivers
 Figure 71. Oncology Targeted Therapy Market Restraints
 Figure 72. Oncology Targeted Therapy Market Trends
 Figure 73. Porters Five Forces Analysis
 Figure 74. Oncology Targeted Therapy Industrial Chain
 Figure 75. Methodology
 Figure 76. Research Process and Data Source

Companies Mentioned

Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere